Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Feb 15;146(4):473–481.

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

A Laupacis 1, D Feeny 1, A S Detsky 1, P X Tugwell 1
PMCID: PMC1488412  PMID: 1306034

Abstract

Because economic evaluations of health care services are being published with increasing frequency it is important to (a) evaluate them rigorously and (b) compare the net benefit of the application of one technology with that of others. Four "levels of evidence" that rate economic evaluations on the basis of their methodologic rigour are proposed. They are based on the quality of the methods used to estimate clinical effectiveness, quality of life and costs. With the use of the magnitude of the incremental net benefit of a technology, therapies can also be classified into five "grades of recommendation." A grade A technology is both more effective and cheaper than the existing one, whereas a grade E technology is less or equally effective and more costly. Those of grades B through D are more effective and more costly. A grade B technology costs less than $20,000 per quality-adjusted life-year (QALY), a grade C one $20,000 to $100,000/QALY and a grade D one more than $100,000/QALY. Many issues other than cost effectiveness, such as ethical and political considerations, affect the implementation of a new technology. However, it is hoped that these guidelines will provide a framework with which to interpret economic evaluations and to identify additional information that will be useful in making sound decisions on the adoption and utilization of health care services.

Full text

PDF
473

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel L. J., Steinberg E. P., Powe N. R., Anderson G. F., Dwyer S. A., Faden R. R. Risk reduction from low osmolality contrast media. What do patients think it is worth? Med Care. 1990 Apr;28(4):324–337. doi: 10.1097/00005650-199004000-00004. [DOI] [PubMed] [Google Scholar]
  2. Avorn J. Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med. 1984 May 17;310(20):1294–1301. doi: 10.1056/NEJM198405173102005. [DOI] [PubMed] [Google Scholar]
  3. Boyle M. H., Torrance G. W. Developing multiattribute health indexes. Med Care. 1984 Nov;22(11):1045–1057. doi: 10.1097/00005650-198411000-00007. [DOI] [PubMed] [Google Scholar]
  4. Boyle M. H., Torrance G. W., Sinclair J. C., Horwood S. P. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med. 1983 Jun 2;308(22):1330–1337. doi: 10.1056/NEJM198306023082206. [DOI] [PubMed] [Google Scholar]
  5. Detsky A. S., Naglie I. G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990 Jul 15;113(2):147–154. doi: 10.7326/0003-4819-113-2-147. [DOI] [PubMed] [Google Scholar]
  6. Fineberg H. V., Scadden D., Goldman L. Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary-care-unit admission. N Engl J Med. 1984 May 17;310(20):1301–1307. doi: 10.1056/NEJM198405173102006. [DOI] [PubMed] [Google Scholar]
  7. Gafni A., Zylak C. J. Ionic versus nonionic contrast media: a burden or a bargain? CMAJ. 1990 Sep 15;143(6):475–478. [PMC free article] [PubMed] [Google Scholar]
  8. Goel V., Deber R. B., Detsky A. S. Nonionic contrast media: economic analysis and health policy development. CMAJ. 1989 Feb 15;140(4):389–395. [PMC free article] [PubMed] [Google Scholar]
  9. Guyatt G. H., Veldhuyzen Van Zanten S. J., Feeny D. H., Patrick D. L. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ. 1989 Jun 15;140(12):1441–1448. [PMC free article] [PubMed] [Google Scholar]
  10. Kirshner B., Guyatt G. A methodological framework for assessing health indices. J Chronic Dis. 1985;38(1):27–36. doi: 10.1016/0021-9681(85)90005-0. [DOI] [PubMed] [Google Scholar]
  11. Linton A. L., Naylor C. D. Organized medicine and the assessment of technology. Lessons from Ontario. N Engl J Med. 1990 Nov 22;323(21):1463–1467. doi: 10.1056/NEJM199011223232106. [DOI] [PubMed] [Google Scholar]
  12. Loomes G., McKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;28(4):299–308. doi: 10.1016/0277-9536(89)90030-0. [DOI] [PubMed] [Google Scholar]
  13. Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989 Apr-Jun;9(2):142–149. doi: 10.1177/0272989X8900900209. [DOI] [PubMed] [Google Scholar]
  14. Naylor C. D., Baigrie R. S., Goldman B. S., Basinski A. Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group. Lancet. 1990 May 5;335(8697):1070–1073. doi: 10.1016/0140-6736(90)92640-4. [DOI] [PubMed] [Google Scholar]
  15. O'Connor A. M., Boyd N. F., Warde P., Stolbach L., Till J. E. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis. 1987;40(8):811–818. doi: 10.1016/0021-9681(87)90133-0. [DOI] [PubMed] [Google Scholar]
  16. Oxman A. D., Guyatt G. H. Guidelines for reading literature reviews. CMAJ. 1988 Apr 15;138(8):697–703. [PMC free article] [PubMed] [Google Scholar]
  17. Rifkin M. D., Zerhouni E. A., Gatsonis C. A., Quint L. E., Paushter D. M., Epstein J. I., Hamper U., Walsh P. C., McNeil B. J. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med. 1990 Sep 6;323(10):621–626. doi: 10.1056/NEJM199009063231001. [DOI] [PubMed] [Google Scholar]
  18. Sacks H. S., Berrier J., Reitman D., Ancona-Berk V. A., Chalmers T. C. Meta-analyses of randomized controlled trials. N Engl J Med. 1987 Feb 19;316(8):450–455. doi: 10.1056/NEJM198702193160806. [DOI] [PubMed] [Google Scholar]
  19. Schieber G. J., Poullier J. P. International health spending and utilization trends. Health Aff (Millwood) 1988 Fall;7(4):105–112. doi: 10.1377/hlthaff.7.4.105. [DOI] [PubMed] [Google Scholar]
  20. Stason W. B., Weinstein M. C. Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension. N Engl J Med. 1977 Mar 31;296(13):732–739. doi: 10.1056/NEJM197703312961307. [DOI] [PubMed] [Google Scholar]
  21. Stein L. I., Test M. A. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry. 1980 Apr;37(4):392–397. doi: 10.1001/archpsyc.1980.01780170034003. [DOI] [PubMed] [Google Scholar]
  22. Stock S. R., Gafni A., Bloch R. F. Universal precautions to prevent HIV transmission to health care workers: an economic analysis. CMAJ. 1990 May 1;142(9):937–946. [PMC free article] [PubMed] [Google Scholar]
  23. Teasdale G. M., Hadley D. M., Lawrence A., Bone I., Burton H., Grant R., Condon B., Macpherson P., Rowan J. Comparison of magnetic resonance imaging and computed tomography in suspected lesions in the posterior cranial fossa. BMJ. 1989 Aug 5;299(6695):349–355. doi: 10.1136/bmj.299.6695.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Torrance G. W., Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5(4):559–575. doi: 10.1017/s0266462300008461. [DOI] [PubMed] [Google Scholar]
  25. Torrance G. W. Measurement of health state utilities for economic appraisal. J Health Econ. 1986 Mar;5(1):1–30. doi: 10.1016/0167-6296(86)90020-2. [DOI] [PubMed] [Google Scholar]
  26. Turnbull J. M., Buck C. The value of preoperative screening investigations in otherwise healthy individuals. Arch Intern Med. 1987 Jun;147(6):1101–1105. [PubMed] [Google Scholar]
  27. Weinstein M. C., Stason W. B. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health. 1985;6:41–63. doi: 10.1146/annurev.pu.06.050185.000353. [DOI] [PubMed] [Google Scholar]
  28. Welch H. G., Larson E. B. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med. 1989 Sep 21;321(12):807–812. doi: 10.1056/NEJM198909213211207. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES